BD Launching BDProbeTec Chlamydia/Gonorrhea Test This Fall Outside U.S.
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson plans to roll out the BDProbeTec ET (energy transfer) in vitro test for molecular diagnosis of Neisseria gonorrheae and Chlamydia trachomatis this fall outside the U.S., the company reported Aug. 4 at the American Association for Clinical Chemistry Conference in Chicago.